DB-OTO – Talk Bio

Actionable Insights Powered by AI

Regeneron Heads to FDA Seeking Approval for Game-Changing Hearing Loss Gene Therapy

2 months ago talkbio0Tagged Approved, CHORD trial, DB-OTO, Deafness, gene therapy, OTOF gene, Regeneron, United States Food and Drug Administration

Regeneron; hearing loss; gene therapy; DB-OTO; FDA approval; OTOF gene; CHORD trial

Regeneron gene therapy improves hearing in 10 children with rare form of hearing loss

10 months ago talkbio0Tagged Congenital deafness, DB-OTO, gene therapy, Injection of therapeutic agent, otoferlin, Regeneron Pharmaceuticals

Regeneron Pharmaceuticals, DB-OTO gene therapy, otoferlin (OTOF) gene, congenital hearing loss, intracochlear injection